Alvotech and Cipla Collaborate to Ensure Access to Biosimilars in South Africa

November 9, 2020 Auto Bot access, Alvotech, Biosimilars, Cipla, Expand, South Africa 0

Shots:

  • Alvotech and Cipla entered an exclusive partnership to provide patients with better access to high quality and cost-effective biosimilar medicines in South Africa
  • Alvotech will be responsible for the development and supply of the products and Cipla will be responsible for the registration and commercialization
  • The biosimilar portfolio will include five biosimilars- two for oncology and three for treating auto-immune diseases

Click here ­to­ read full press release/ article | Ref: Alvotech | Image: Formycon

The post Alvotech and Cipla Collaborate to Ensure Access to Biosimilars in South Africa first appeared on PharmaShots.